Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance

Author:

Aljada Ahmad,Saleh Ayman M,Al Suwaidan Salem

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference55 articles.

1. Zapf J, Froesch ER: Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res. 1986, 24: 121-130. 10.1159/000180551.

2. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 1990, 50: 48-53.

3. Gross GE, Boldt DH, Osborne CK: Perturbation by insulin of human breast cancer cell cycle kinetics. Cancer Res. 1984, 44: 3570-3575.

4. Myal Y, Shiu RP, Bhaumick B, Bala M: Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Cancer Res. 1984, 44: 5486-5490.

5. Rasmussen AA, Cullen KJ: Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res Treat. 1998, 47: 219-233. 10.1023/A:1005903000777.

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Blocking of SIRT7/FOXO3a Axis by miR-152-3p Enhances Cisplatin Sensitivity in Breast Cancer;The American Journal of the Medical Sciences;2024-09

2. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway;Journal of Natural Medicines;2024-02-07

3. SIRT7: the seventh key to unlocking the mystery of aging;Physiological Reviews;2024-01-01

4. The strategic involvement of IRS in cancer progression;Biochemical and Biophysical Research Communications;2023-11

5. Does insulin make breast cancer cells resistant to doxorubicin toxicity?;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3